Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03963908 · ClinicalTrials.gov registry record · NA
Evidence-based Pain Intervention for Veterans: AtEase for Chronic Pain
A NA study of Chronic Pain, sponsored by Pro-Change Behavior Systems.
- Completed
- Registry status
- NA
- Development phase
- 268
- Enrollment target
- 2
- Study locations
NCT03963908: Completed NA study of Chronic Pain, sponsored by Pro-Change Behavior Systems.
NCT03963908 is a NA study of Chronic Pain that has completed, run by Pro-Change Behavior Systems. The registered enrollment target is 268 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (65% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03963908, a NA study of Chronic Pain, has completed, sponsored by Pro-Change Behavior Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 268 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is a randomized controlled trial to test the efficacy AtEase, a pain self-management app in a sample of Veterans with chronic musculoskeletal pain. The primary outcome is changes in PEG scores from baseline to final follow-up (12 months).
Primary Outcome
The PEG is a multi-dimensional three-item assessment that measures average pain rating, as well as both emotional and physical functioning.
Conditions Studied
Interventions
- BEHAVIORAL AtEase
- BEHAVIORAL Chronic Pain Education
Study Locations (2)
Connecticut
- VA Connecticut Healthcare System - West Haven
Rhode Island
- Pro-Change Behavior Systems, Inc - South Kingstown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2019-09-15 |
| Est. Completion | 2021-04-12 |
| Phase | NA |
What the finished NCT03963908 record still lists
NCT03963908 is an interventional study that assigns participants to a tested intervention. The registered 268 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which AtEase is the first listed.
NCT03963908 reports a single indexed study location in Connecticut, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT03963908 about?
NCT03963908 is a clinical study titled "Evidence-based Pain Intervention for Veterans: AtEase for Chronic Pain". This study is a randomized controlled trial to test the efficacy AtEase, a pain self-management app in a sample of Veterans with chronic musculoskeletal pain. The primary outcome is changes in PEG scores from baseline to final follow-up (12 months).
What is the current status of trial NCT03963908?
This trial is currently completed. It is a NA study. The enrollment target is 268 participants. The study started on 2019-09-15. Estimated completion is 2021-04-12.
What conditions does trial NCT03963908 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT03963908?
The interventions under investigation include: AtEase (BEHAVIORAL), Chronic Pain Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT03963908?
This trial is sponsored by Pro-Change Behavior Systems, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03963908 being conducted?
This trial has 2 study locations across Connecticut, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03963908's enrollment target sits among peer trials
268 60th of 301 higher than 241 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
- NCT05797831 · 268 participants · Phase 2
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- NCT05997381 · 268 participants · NA
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
- NCT06233461 · 268 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI